Target expression details
| Target General Information | |||||
|---|---|---|---|---|---|
| Target ID | T14676 | ||||
| Target Name | A proliferation-inducing ligand | ||||
| Synonyms | A proliferation-inducing ligand; CD256; TALL-2; TNF- and APOL-related leukocyte expressed ligand 2; TNF-related death ligand 1; TRDL-1; Tumor necrosis factor ligand superfamily member 13; TNFSF13 | ||||
| Target Type | Clinical Trial | ||||
| Gene Name | TNFSF13 | ||||
| Biochemical Class | Cytokine: tumor necrosis factor | ||||
| UniProt ID | TNF13_HUMAN | ||||
| Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
| Disease | Multiple sclerosis | ||||
| Example drug | Atacicept | Phase 2 | [530405], [537129], [1572592] | ||
| Tissue | Spinal cord | ||||
| Level of differential expression between the patients in the disease section of the tissue and the patients in the normal section of the tissue adjacent to the disease section | Fold-change: 0.13 Z-score: 0.79 P-value: 2.89E-01 |
||||
|
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles of the patients in the normal section of the tissue adjacent to the disease section
|
|||||
| Disease | Rheumatoid arthritis | ||||
| Example drug | Atacicept | Phase 2 | [530405], [537129], [1572592] | ||
| Tissue | Synovial tissue | ||||
| Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: -0.20 Z-score: -0.46 P-value: 3.53E-01 |
||||
|
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.